Mongrel Mob open up to Otago researchers for the good of their health

August 29, 2018

Studying the liver health of a high-risk, hard-to-reach gang population certainly came with challenges and a few surprises, a University of Otago academic says.

The research, published today in Royal Society Open Science, assessed the hepatitis prevalence, knowledge, and liver health risk factors of 52 Mongrel Mob members, affiliates and extended family.

Associate Professor Michael Schultz, Head of the Department of Medicine, says New Zealand has a high percentage of undiagnosed hepatitis B and C cases.

The Mongrel Mob is the largest gang in New Zealand and, thanks to known risk factors for hepatitis C, such as a high incarceration rate, common intravenous drug use, and uncertified tattooing, their members and relatives are considered to be a high-risk hepatitis C group.

"Knowledge of hepatitis and how it is transmitted are essential for disease prevention and management," he says.

Dr Schultz says the researchers were provided with a unique opportunity to study the Mongrel Mob, a group considered to be hard-to-reach and marginalised, generating the first data of this kind.

While no cases of hepatitis C were found, two carriers of hepatitis B were identified.

Of most concern was the "marginal" knowledge the study participants had about viral hepatitis. On average, the participants scored 43.3 per cent on a knowledge questionnaire, compared to 59.4 per cent in the general population.

"Knowledge about some aspects of viral hepatitis, such as risk factors, transmission, symptoms and treatment options was very low," Dr Schultz says.

The researchers found a significant link between lack of knowledge and risky infection behaviours among the group.

"Education is key to stopping hepatitis C from spreading. This study demonstrates the need for educational screening programmes to aid early detection, prevention and treatment," he says.

The researchers also identified several areas of concern about the general liver health of the group: participants displayed three times higher rates of liver inflammation and damage compared to the general population; one-fifth had significant to severe levels of liver fibrosis and cirrhosis; exceptionally high levels of alcohol consumption, in both frequency and quantity, were identified; and the group was found to have more than two times higher obesity rates than the general population.

"Given that about 35 per cent of the group visited their GP less than once every five years, they are highly concerning findings," Dr Schultz says.

While surprised by the willingness of the participants to be involved in the study, Dr Schultz believed having a person on the team who came from a gang family helped break the ice.

"While the planning wasn't all that easy, once there, everybody was really open, interested, and asked questions. We felt welcome, not threatened at all. They were very nice and co-operative and really interested, despite what we think we know about the Mongrel Mob.

"I see this as one of the most interesting and challenging projects I have done. It certainly took me out of my comfort zone."

He was particularly pleased the study provided a unique opportunity to engage with an entire community, and provide knowledge that disseminated outside the immediate study group.

The Mongrel Mob has also worked with Otago academics to study lung function and smoking habits. Dr Schultz believes there is scope to also work with the gang on projects targeting diabetes and hypertension, though nothing is currently planned.

As it proved such a successful model for community-based educational health intervention, the study format could also be extended to other subjects.

"With some persistence and good planning, it is possible to reach these people."
Publication details:

A liver health hui: hepatitis C knowledge and associated risk factors in New Zealand gang members and their families

Kristina Aluzaite, Jordan Tewhaiti-Smith, Margaret Fraser, Steve Johnson, Elizabeth Glen, Allison Beck, Barbara Smith, Jack Dummer, and Michael Schultz.

Royal Society Open Science

For more information, contact:

Associate Professor Michael Schultz
Head of Department of Medicine
University of Otago
Tel 03 474 0999

University of Otago

Related Hepatitis Articles from Brightsurf:

Busting Up the Infection Cycle of Hepatitis B
Researchers at the University of Delaware have gained new understanding of the virus that causes hepatitis B and the ''spiky ball'' that encloses its genetic blueprint.

Liver cancer: Awareness of hepatitis D must be raised
Scientists from the University of Geneva (UNIGE) and the Geneva University Hospitals (HUG) have studied the most serious consequence of chronic hepatitis: hepatocellular carcinoma.

Hepatitis B: New therapeutic approach may help to cure chronic hepatitis B infection
Researchers at Helmholtz Zentrum München, Technical University of Munich (TUM) and the German Center for Infection Research (DZIF) have developed a novel therapeutic approach to cure chronic hepatitis B.

Anti-hepatitis medicine surprises
A new effective treatment of hepatitis C not only combats the virus, but is also effective against potentially fatal complications such as reduced liver functioning and cirrhosis.

Nanotechnology delivers hepatitis B vaccine
X-ray imaging shows that nanostructured silica acts as a protective vehicle to deliver intact antigen to the intestine so that it can trigger an immune response.

Checkmate for hepatitis B viruses in the liver
Researchers at Helmholtz Zentrum München and the Technical University of Munich, working in collaboration with researchers at the University Medical Center Hamburg-Eppendorf and the University Hospital Heidelberg, have for the first time succeeded in conquering a chronic infection with the hepatitis B virus in a mouse model.

How common is Hepatitis C infection in each US state?
Hepatitis C virus infection is a major cause of illness and death in the United States and injection drug use is likely fueling many new cases.

New strains of hepatitis C found in Africa
The largest population study of hepatitis C in Africa has found three new strains of the virus circulating in the general population in sub-Saharan Africa.

High stability of the hepatitis B virus
At room temperature, hepatitis B viruses (HBV) remain contagious for several weeks and they are even able to withstand temperatures of four degrees centigrade over the span of nine months.

Findings could lead to treatment of hepatitis B
Researchers have gained new insights into the virus that causes hepatitis B -- a life-threatening and incurable infection that afflicts more than 250 million people worldwide.

Read More: Hepatitis News and Hepatitis Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to